China Universal Asset Management »

Akero Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $273k 11k 25.28
2023-12-31 $151k 6.4k 23.41
2023-09-30 $72k 1.4k 50.49
2023-06-30 $34k 725 46.90
2023-03-31 $24k 634 37.85
2022-12-31 $26k 475 54.74
2022-09-30 $12k 352 34.09

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Akero Therapeutics

Henderson Group
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Yiheng Capital
Boxer Capital
Alliancebernstein
Redmile Group
Perceptive Advisors
Logos Global Management
Point72 Asset Management
Citadel Advisors
Goldman Sachs Group
Holocene Advisors

View all funds holding Akero Therapeutics